"We're not waiting to see how the bankruptcy goes," said the university's lawyer.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Democrat Rob Sand is emerging as one of his party’s most closely ...

As Trump’s approval ratings dip and gas prices rise, Democrats see an opening with Rob Sand Rob Sand, the best-known Democrat in Iowa, appears on podcasts to discuss his love of hunting, begins ...

GENEVA, May 12 (Reuters) - Growing global demand for sand, driven by rapid urbanisation and construction, is exceeding sustainable supply and putting ecosystems and livelihoods at risk, ‌the United ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

A team of researchers based in Norway and Japan might soon have you walking on desert sand, no matter how far from the dunes you live. This group of engineers has developed a method to transform it ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...